Filter
Reset all

Subjects

Content Types

Countries

API

Data access

Data access restrictions

Database access

Database access restrictions

Database licenses

Data licenses

Data upload

Enhanced publication

Institution responsibility type

Institution type

Keywords

Metadata standards

PID systems

Provider types

Quality management

Repository languages

Software

Repository types

Versioning

  • * at the end of a keyword allows wildcard searches
  • " quotes can be used for searching phrases
  • + represents an AND search (default)
  • | represents an OR search
  • - represents a NOT operation
  • ( and ) implies priority
  • ~N after a word specifies the desired edit distance (fuzziness)
  • ~N after a phrase specifies the desired slop amount
  • 1 (current)
Found 3 result(s)

Zentrale Biomaterialbank der Charité

Central Biomaterial Bank Charité

Subject(s)
Content type(s)
Country
Human biomaterial banks (short: biobanks) are collections of human body substances (i.e. blood, DNA, urine or tissue) connected with disease specific information. This allow for research of relations between deseases and underlying (molecular) modifications and paves the way for developing target-oriented therapies ("personalized medicine"). The biobank material arises from samples taken for therapeutical or diagnostic reasons or is extracted in the context of clinical trials. An approval for usage by the patient is always needed prior to any research activities.

The Polinsky Language Sciences Lab Dataverse

Subject(s)
Content type(s)
Country
The Polinsky Language Sciences Lab at Harvard University is a linguistics lab that examines questions of language structure and its effect on the ways in which people use and process language in real time. We engage in linguistic and interdisciplinary research projects ourselves; offer linguistic research capabilities for undergraduate and graduate students, faculty, and visitors; and build relationships with the linguistic communities in which we do our research. We are interested in a broad range of issues pertaining to syntax, interfaces, and cross-linguistic variation. We place a particular emphasis on novel experimental evidence that facilitates the construction of linguistic theory. We have a strong cross-linguistic focus, drawing upon English, Russian, Chinese, Korean, Mayan languages, Basque, Austronesian languages, languages of the Caucasus, and others. We believe that challenging existing theories with data from as broad a range of languages as possible is a crucial component of the successful development of linguistic theory. We investigate both fluent speakers and heritage speakers—those who grew up hearing or speaking a particular language but who are now more fluent in a different, societally dominant language. Heritage languages, a novel field of linguistic inquiry, are important because they provide new insights into processes of linguistic development and attrition in general, thus increasing our understanding of the human capacity to maintain and acquire language. Understanding language use and processing in real time and how children acquire language helps us improve language study and pedagogy, which in turn improves communication across the globe. Although our lab does not specialize in language acquisition, we have conducted some studies of acquisition of lesser-studied languages and heritage languages, with the purpose of comparing heritage speakers to adults.

CaPSURE

Cancer of the Prostate Strategic Urologic Research Endeavor

Subject(s)
Content type(s)
Country
CaPSURE™ is a longitudinal, observational study of approximately 15,000 men with all stages of biopsy-proven prostate cancer. Patients have enrolled at 43 community urology practices, academic medical centers, and VA hospitals throughout the United States since 1995. CEASAR stands for Comparative Effectiveness Analysis of Surgery and Radiation. The ongoing goal of CEASAR is to help learn more about what prostate cancer treatments work best, for which patients, in whose hands. There are currently about 3,600 men with a prostate cancer diagnosis participating in CEASAR. Three rounds of surveys have been completed, with the first carried out in the spring of 2010. We are currently in the process of conducting our fourth survey with the same group of men in our study. This survey, our Three Year Follow-up, will occur throughout the summer of 2014.